Search Results

There are 32164 results for: content related to: CGS 12970: a novel, long acting thromboxane synthetase inhibitor

  1. Pharmacokinetics of CGS 12970 and inihibition of thromboxane synthesis after oral administration in healthy adults

    Clinical Pharmacology & Therapeutics

    Volume 49, Issue 4, April 1991, Pages: 433–441, Louis L Martin, A Victoria Schaffer, Anthony Piraino, Leonid Linberg, Kuldeep Singh, Ashok Rakhit and Frank L Douglas

    Version of Record online : 28 APR 1991, DOI: 10.1038/clpt.1991.51

  2. Preliminary Observations of the Acute Effects of Selective Serum Thromboxane Inhibition and Angiotensin Converting Enzyme Inhibition on Blood Pressure and Renal Hemodynamics in Hypertensive Humans

    The Journal of Clinical Pharmacology

    Volume 29, Issue 12, December 1989, Pages: 1108–1116, Dr. Matthew R. Weir, Dr. David K. Klassen, Dr. Nancy Hoover and Dr. Frank L. Douglas

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1989.tb03287.x

  3. You have full text access to this Open Access content
    Treatment of Membranopr oliferative Glomerulonephritis and Nephrotic Syndrome in a Dog with a Thromboxane Synthetase Inhibitor

    Journal of Veterinary Internal Medicine

    Volume 6, Issue 2, March 1992, Pages: 77–81, Gregory F. Grauer, David D. Frisbie, Patti S. Snyder, Richard R. Dubielzig and David L. Panciera

    Version of Record online : 5 FEB 2008, DOI: 10.1111/j.1939-1676.1992.tb03155.x

  4. Effects of a 48 hour continous intravenous infusion of CGS 13080-primagrel, a selective thromboxane synthetase inhibitor, on the perinatal and early postnatal period in the guinea pig

    Teratology

    Volume 46, Issue 2, August 1992, Pages: 159–167, Dr. J. Keith Jr., T. Rowles, K. Warwick and E. Yau

    Version of Record online : 2 JUN 2005, DOI: 10.1002/tera.1420460209

  5. Uricosuric effect of CGS-12970, a new thromboxane synthase inhibitor

    Clinical Pharmacology & Therapeutics

    Volume 54, Issue 1, July 1993, Pages: 65–69, Steven D Saris, Anthony J Piraino, John M Morgan, William L Hirschhorn, Erik Meidl and A Victoria Schaffer

    Version of Record online : 11 JUL 1993, DOI: 10.1038/clpt.1993.112

  6. CGS 22652: A New Potent Thromboxane A2 Receptor Antagonist with Selective Thromboxane A2 Synthase Inhibitory Properties

    Cardiovascular Drug Reviews

    Volume 10, Issue 4, December 1992, Pages: 379–391, David S. Cohen, Donald N. McMartin, Michael P. Marietta, Patricia A. Zane and Rodney W. Lappe

    Version of Record online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1992.tb00257.x

  7. BLOOD PRESSURE EFFECTS OF THROMBOXANE A2 BLOCKADE IN SPONTANEOUSLY HYPERTENSIVE RATS

    Clinical and Experimental Pharmacology and Physiology

    Volume 20, Issue 11, November 1993, Pages: 679–687, El Habib Boussairi, Joëlle Sacquet, Daniel Benzoni and Jean Sassard

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1993.tb01652.x

  8. The Effects of a New Thromboxane Synthetase Inhibitor, CGS-13080, in Man

    The Journal of Clinical Pharmacology

    Volume 24, Issue 2-3, February-March 1984, Pages: 76–83, MALCOLM W. MACNAB, E. L. FOLTZ, BETTY S. GRAVES, ROY K. RINEHART, SPENCER L. TRIPP, NANCY R. FELICIANO and SUPRADIP SEN

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1984.tb02768.x

  9. Prostaglandins, prostacyclin, and thromboxane in cardiovascular diseases

    Drug Development Research

    Volume 7, Issue 4, April 1986, Pages: 341–359, Dr. Peter S. Chan and Peter Cervoni

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430070406

  10. Thromboxane A2 and related prostaglandins in airways

    Fundamental & Clinical Pharmacology

    Volume 11, Issue 1, January-February 1997, Pages: 2–18, P. Devillier and G. Bessard

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1472-8206.1997.tb00163.x

  11. A quantitative analytical method for the determination of a new thromboxane synthetase inhibitor (CGS 22652) in human plasma using high performance liquid chromatography

    Biomedical Chromatography

    Volume 8, Issue 5, September/October 1994, Pages: 247–250, M. S. Stelling, W. M. Maniara and M. L. Powell

    Version of Record online : 6 APR 2005, DOI: 10.1002/bmc.1130080510

  12. You have free access to this content
    Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat

    British Journal of Pharmacology

    Volume 78, Issue 4, April 1983, Pages: 725–732, Katherine Anderegg, Peter Anzeveno, James A. Cook, Perry V. Halushka, James McCarthy, Eugene Wagner and William C. Wise

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1983.tb09426.x

  13. You have free access to this content
    Pathophysiological mechanisms of sudden death induced by platelet activating factor

    British Journal of Pharmacology

    Volume 83, Issue 1, September 1984, Pages: 125–130, Allan M. Lefer, Hugo F. Müller and J. Bryan Smith

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1984.tb10126.x

  14. Inhibitory effect of inhalation of a thromboxane synthetase inhibitor on bronchoconstriction induced by aerosolized leukotriene C4 and thromboxane A2 analogue in anesthetized guinea pigs

    Allergy

    Volume 46, Issue 7, October 1991, Pages: 534–539, M. Fujimura, H. Ogawa, M. Saito, S. Sakamoto, Y. Miyake and T. Matsuda

    Version of Record online : 28 APR 2007, DOI: 10.1111/j.1398-9995.1991.tb00617.x

  15. You have free access to this content
    Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177)

    British Journal of Pharmacology

    Volume 87, Issue 4, May 1986, Pages: 631–637, Karsten Schrör and Christoph Thiemermann

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1986.tb14579.x

  16. Selective and nonselective inhibition of thromboxane formation

    Clinical Pharmacology & Therapeutics

    Volume 35, Issue 5, May 1984, Pages: 633–640, Garret A Fitzgerald and John A Oates

    Version of Record online : 9 MAY 1984, DOI: 10.1038/clpt.1984.87

  17. EFFECTS OF THROMBOXANE SYNTHETASE INHIBITOR (UK 38,485) AND THROMBOXANE RECEPTOR ANTAGONIST (ICI 185,282) ON DIGOXIN-INDUCED ARRHYTHMIAS IN ANAESTHETIZED GUINEA-PIGS

    Clinical and Experimental Pharmacology and Physiology

    Volume 15, Issue 12, December 1988, Pages: 927–935, I. Kanzik, A. T. Demiryürek, H. Zengil, N. Abacioǧlu and H. Dörtlemez

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-1681.1988.tb01038.x

  18. You have free access to this content
    Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation

    British Journal of Pharmacology

    Volume 99, Issue 3, March 1990, Pages: 461–466, Mark O. Aksoy, Concetta Harakal, J. Bryan Smith, Gwendolyn J. Stewart and Charles R. Zerweck

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1990.tb12950.x

  19. You have free access to this content
    ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro

    British Journal of Pharmacology

    Volume 110, Issue 4, December 1993, Pages: 1600–1606, R.P. Brownlie, N.J. Brownrigg, H.M. Butcher, R. Garcia, R. Jessup, V.J. Lee, S. Tunstall and M.G. Wayne

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1993.tb14007.x

  20. The role of the endothelium in arterial thrombosis and the influence of antithrombotic therapy

    Drug Development Research

    Volume 7, Issue 4, April 1986, Pages: 319–340, Dr. Larry R. Bush and Darryl Patrick

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430070405